Alpha 2.0
Login Register
» Articles » PMID: 25446726

Oesophageal Cancer in 2014: Advances in Curatively Intended Treatment

Overview
Journal Nat Rev Gastroenterol Hepatol
Specialty Gastroenterology
Date 2014 Dec 3
PMID 25446726
Citations 11
Authors
Jesper Lagergren
Affiliations
Soon will be listed here.
Citing Articles

Biological roles of RNA m7G modification and its implications in cancer.

Zhang X, Zhu W, Shen S, Shen J, Chen X Biol Direct. 2023; 18(1):58.

PMID: 37710294 PMC: 10500781. DOI: 10.1186/s13062-023-00414-5.

Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.

Holmberg D, Gottlieb-Vedi E, Hedberg J, Lindblad M, Mattsson F, Lagergren J BMC Cancer. 2023; 23(1):375.

PMID: 37098462 PMC: 10127395. DOI: 10.1186/s12885-023-10819-0.

Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.

Zhang L, Chen J, Cheng T, Yang H, Pan C, Li H Biomed Res Int. 2020; 2020:1980921.

PMID: 32714975 PMC: 7352135. DOI: 10.1155/2020/1980921.

miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1.

Hu C, Peng J, Lv L, Wang X, Zhou Y, Huo J Oncol Lett. 2019; 17(6):5201-5209.

PMID: 31186736 PMC: 6507485. DOI: 10.3892/ol.2019.10186.

IL-1RA suppresses esophageal cancer cell growth by blocking IL-1α.

Chen S, Shen Z, Liu Z, Gao L, Han Z, Yu S J Clin Lab Anal. 2019; 33(6):e22903.

PMID: 31102307 PMC: 6642324. DOI: 10.1002/jcla.22903.

References
1.
Oppedijk V, van der Gaast A, van Lanschot J, van Hagen P, van Os R, van Rij C . Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014; 32(5):385-91. DOI: 10.1200/JCO.2013.51.2186. View
2.
Shaheen N, Sharma P, Overholt B, Wolfsen H, Sampliner R, Wang K . Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22):2277-88. DOI: 10.1056/NEJMoa0808145. View
3.
Merkow R, Bilimoria K, Keswani R, Chung J, Sherman K, Knab L . Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014; 106(7). DOI: 10.1093/jnci/dju133. View
4.
Mariette C, Dahan L, Mornex F, Maillard E, Thomas P, Meunier B . Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014; 32(23):2416-22. DOI: 10.1200/JCO.2013.53.6532. View
5.
van Meerten E, van der Gaast A, Tilanus H, Poley J, Muller K, van Dekken H . Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience. J Surg Oncol. 2009; 100(1):32-7. DOI: 10.1002/jso.21295. View